Cogent Biosciences, Inc. (COGT) Return on equity 2019–2021
Cogent Biosciences, Inc. (COGT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-30.8%FY2021 · since FY2019: -52.8% → -30.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -30.8% | +204.7 pp |
| FY2020 | -235.5% | -182.7 pp |
| FY2019 | -52.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More COGT financial trends
COGT RevenueCOGT Net incomeCOGT Net marginCOGT Gross profitCOGT Gross marginCOGT Operating incomeCOGT Operating marginCOGT Operating cash flowCOGT Free cash flowCOGT Capital expendituresCOGT Stock buybacksCOGT Dividends paidCOGT Total assetsCOGT Total liabilitiesCOGT Shareholders’ equityCOGT overview →